- Research article
- Open Access
In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis
© Ibrahim-Granet et al; licensee BioMed Central Ltd. 2010
Received: 1 June 2009
Accepted: 8 April 2010
Published: 8 April 2010
Invasive aspergillosis (IA) is a major cause of infectious morbidity and mortality in immune compromised patients. Studies on the pathogenesis of IA have been limited by the difficulty to monitor disease progression in real-time. For real-time monitoring of the infection, we recently engineered a bioluminescent A. fumigatus strain.
In this study, we demonstrate that bioluminescence imaging can track the progression of IA at different anatomic locations in a murine model of disease that recapitulates the natural route of infection. To define the temporal and functional requirements of distinct innate immune cellular subsets in host defense against respiratory A. fumigatus infection, we examined the development and progression of IA using bioluminescence imaging and histopathologic analysis in mice with four different types of pharmacologic or numeric defects in innate immune function that target resident and recruited phagocyte subsets. While bioluminescence imaging can track the progression and location of invasive disease in vivo, signals can be attenuated by severe inflammation and associated tissue hypoxia. However, especially under non-inflammatory conditions, such as cyclophosphamide treatment, an increasing bioluminescence signal reflects the increasing biomass of alive fungal cells.
Imaging studies allowed an in vivo correlation between the onset, peak, and kinetics of hyphal tissue invasion from the lung under conditions of functional or numeric inactivation of phagocytes and sheds light on the germination speed of conidia under the different immunosuppression regimens. Conditions of high inflammation -either mediated by neutrophil influx under corticosteroid treatment or by monocytes recruited during antibody-mediated depletion of neutrophils- were associated with rapid conidial germination and caused an early rise in bioluminescence post-infection. In contrast, 80% alveolar macrophage depletion failed to trigger a bioluminescent signal, consistent with the notion that neutrophil recruitment is essential for early host defense, while alveolar macrophage depletion can be functionally compensated.
Morbidity and mortality caused by invasive Aspergillus infections are increasing due to an expansion in the number of patients receiving potent myeloablative and immunosuppressive regimens for transplantation and the treatment of malignancy and autoimmune disorders [1, 2]. Patients with hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplants (HSCT) belong to high-risk groups for invasive aspergillosis (IA).
IA is the most common invasive mould infection in immunocompromised patients. Although neutropenia following the conditioning regimen remains an important risk factor for IA in the early post-transplant period, most cases of IA in allogeneic HSCT recipients occur after neutrophil recovery in the setting of potent immunosuppressive therapy for graft-versus-host disease (GVHD). This treatment of GVHD in the late post-transplant period with corticosteroids and potent immunosuppressive therapy contributes to the risk for IA [3–7].
In immune competent hosts, pulmonary alveolar macrophages (AM) coordinate the early inflammatory response and ingest and kill the inhaled conidia [8, 9]. Besides ingesting inhaled conidia, AMs are believed to play a key role in orchestrating the inflammatory response to A. fumigatus. Pattern recognition receptors (PRR) on AM recognize specific fungal cell wall motifs displayed during the conidial and hyphal stages and produce cytokines and chemokines that stimulate neutrophil recruitment and subsequent antigen-specific immunity. Recent studies have demonstrated the key role of PRR in regulating innate and antigen-dependent immunity in response to fungal infections [10, 11]. For instance, β-glucan that is exposed on the surface of Aspergillus germinating conidia and hyphal cells (but not resting conidia) is recognized by the C-type lectin, dectin-1 [12–14].
In addition to AMs, other innate immune cells that include neutrophils, monocytes and NK T cells have important antifungal effector roles. The critical role of neutrophils has been substantiated by the high risk of IA in patients who have severe and prolonged neutropenia and the lethal course of IA in neutropenic murine models .
Although the past few years have witnessed advances in our understanding of the pathophysiology of IA, our understanding of the disease process and the host response has been hampered by the inability to follow in vivo fungal growth and dissemination in real time.
We recently generated a bioluminescent A. fumigatus strain, which constitutively expresses the luciferase from Photinus pyralis under control of the glyceraldehyde-3-phosphate dehydrogenase promoter. We showed that the bioluminescence of this strain correlated well with fungal biomass under in vitro conditions and demonstrated that using bioluminescence imaging enables researchers to monitor the onset of pulmonary IA in corticosteroid-treated mice .
In the present study we applied bioluminescence imaging to an animal model of IA by using different immunosuppression regimens that affect either AM and/or neutrophil number or function. The primary aim of this study was to evaluate the suitability of in vivo and ex vivo bioluminescence imaging to monitor the development of invasive aspergillosis. Bioluminescence imaging was combined with quantitative fungal DNA determination, histopathologic and morphometric analysis of infected lung tissues to assess the fungal burden and progression of IA, the timing and pattern of extrapulmonary dissemination, and the development of inflammatory cell infiltrates in the lung. Our results suggest that neutrophils, rather than AM, play an indispensable role in host defense against A. fumigatus.
Pathogenesis of invasive aspergillosis following different immunosuppression regimens
Neutrophils were depleted by using the monoclonal antibody RB6-8C5, which binds the myeloid differentiation antigen Gr-1 and leads to neutropenia lasting for three to four days at the dose administered in our experiments . In agreement with prior studies, transient neutropenia was sufficient to cause lethal pulmonary aspergillosis (Figure 1B) . However, weight loss of mice treated with RB6-8C5 was less pronounced than observed with the other immunosuppressive regimens (Figure 1A).
We also targeted resident alveolar macrophages by intranasal instillation of liposomes containing clodronate (clodrolip). Phagocytosis of clodrolip leads to an intracellular accumulation of clodronate and the induction of macrophage apoptosis . To confirm that the observed effects were not due to the instillation with liposomes, empty liposomes served as a control. The 20% loss of treated mice shown in Figure 1A is due to the accidental death of one mouse that displayed pulmonary haemorrhages after drug administration, at necropsy. After infection, none of the mice treated with clodrolip showed severe signs of illness and weight loss was transient (Figure 1A and 1B).
Bioluminescence imaging of infected mice
To understand the specific impact of each immunosuppression regimen on fungal growth, we performed in vivo bioluminescence measurements in different infected cohorts of mice using A. fumigatus strain C3. Subsequently, we performed histopathologic analyses to correlate the light emission pattern with fungal invasion and immune effector cell recruitment.
Figure 1C shows a time response of the quantification of the luminescence from the thorax of animals treated with the different immunosuppressive agents. As previously observed, light emission peaked between day one and two post-infection in cortisone acetate-treated mice. A peak in the bioluminescence signal at day two post-infection was observed in mice that received the RB6-8C5 antibody. However, the thoracic signal intensity was much weaker in RB6-8C5-treated mice than in cortisone acetate-treated mice and hardly exceeded the background intensity. Despite the low signal intensity, all mice died four or five days post-infection. Cyclophosphamide treatment, in contrast, induced a more gradual rise in bioluminescence on day three post-infection. The signal intensity continued to increase and remained at a high level until death of the animals at day five post-infection, implying that biomass formation may correlate best with bioluminescence development under this immunosuppresive treatment. Mice treated with clodrolip did not show overt signs of disease and the bioluminescence signal remained near the imaging threshold of approximately 5 × 104 - 1 × 105 total photon flux per second. This result suggested that despite AM depletion, no significant hyphal growth occurred after clodrolip treatment.
In summary, these results suggest that the rapid increase in bioluminescence, observed in cortisone acetate-treated mice in particular, but also in RB6-8C5-treated mice, reflects early conidial germination post-infection.
Correlation of bioluminescence signals with fungal burden in infected mouse lungs
In contrast, treatment with the cytostatic drug cyclophosphamide prevents the recruitment of immune effector cells to the side of infection. Therefore, despite a retarded germination of conidia, fungal hyphae stay alive, which is well visualized by the massive increase in fungal DNA determined at the late stage of infection (Figure 2). In agreement, the bioluminescence steadily increased under this regimen and explanted lungs show a 50 - 100 times higher light emission than observed under corticosteroid treatment. This result shows that bioluminescence measurements and DNA quantification correlate best under the cyclophophamide regimen. Although the bioluminescence readout does not correlate linearily with the fungal burden as measured by qRT-PCR, the general tendency of increasing and decreasing fungal burden as well as the impact of the inflammatory response seems well reflected by bioluminescence imaging.
Impact of immunosuppression regimens on the inflammatory response
In order to correlate survival curves, weight loss, fungal burden from DNA quantification and bioluminescence with histopathological findings, additional experiments were performed, in which mice were sacrificed one day (early) and three days (late) post infection. For the clodrolip condition, mice were sacrificed eight days after infection to assess any later effect of treatment on mice survival. Lungs were removed, and thin sections were studied for the evaluation of the recruitment of immune effector cell lineages and fungal tissue invasion.
Lung instillation with clodrolip was expected to reduce the number of AM, which are generally denoted as the first cellular line of host innate immune defense through phagocytosis and killing of inhaled conidia. To confirm the reduction in the number of AM, the BAL fluid of non-infected mice were sampled two days after intranasal administration of clodrolip or liposomes, respectively. Flow cytometry was used to quantify the number of AM within the BAL fluid. The clodrolip treatment resulted in a numeric depletion of 60% of AM (8.30 × 104 ± 1 × 104 versus 2.03 × 105 ± 1.8 × 104) when compared to control liposome treated animals (p < 0.05). Furthermore, the viability of the residual AM subset was only 50% as evaluated by trypan blue staining. Taken together, clodrolip treatment depleted or resulted in the death of 80% of AM compared to control mice.
Furthermore, we performed an evaluation of the luminescence in the BAL one day after infection, comparing clodrolip versus liposomes (control) or cortisone acetate treated mice. Cortisone acetate was used as a positive control for fungal germination within the lung tissue, because we previously showed that cortisone acetate inhibits the killing capacity of AM and resulted in the germination of conidia even one day after infection [20, 21]. Mice treated with clodrolip had a fourfold lower BAL luminescence signal than cortisone actetate-treated mice (102000 ± 37000 versus 394000 ± 19500 photons flux) (Figure 3B), consistent with the finding that preserved airway neutrophil recruitment under these conditions can inhibit the conidial germination. However, although not significantly different, the signal in the BAL from clodrolip treated mice was higher than that of liposome treated control mice (102000 ± 37000 versus 66300 ± 19500). Nevertheless, germination and mycelium formation was inhibited in AM-depleted mice as confirmed by lung histopathology analyses performed one and eight days post infection (see below).
Neutrophils may act as the first line of defense against conidia
Comparison between the lesion profiles in the different immunosuppressive conditions.
Recruted Inflammatory Cells
Proportion of inflammatory infiltrate surface
1 day PI
1.8 ± 1.0%
8 days PI
2.9 ± 1.7%
1 day PI
3.8 ± 2.0%
3 days PI
11.2 ± 1.9%
1 day PI
1.9 ± 0.5%
3 days PI
18.9 ± 2.8%
1 day PI
3 days PI
Cortisone acetate treatment versus the combination of cortisone acetate and clodrolip
Neutrophils encircle A. fumigatus conidia and limit their infiltrative potential, but fail to prevent their germination under corticosteroid-treatment
In comparison to clodrolip-treated mice (Table 1), cortisone acetate-treated mice exhibited a higher and more severe level of pulmonary parenchyma destruction, and conidia and hyphae were at a more advanced stage of maturation.
The same pattern of severe lesions was observed after the clodrolip/cortisone acetate treatment (data not shown). Therefore, depletion of alveolar macrophages does not exhibit additional effects on the development of invasive aspergillosis in the presence of cortisone acetate.
Collectively, these results suggest that in the cortisone acetate condition, the early infiltration of neutrophils results in parenchymal destruction without stopping conidial germination. Three days post infection, neutrophils encircling A. fumigatus conidia and hyphae may limit fungal spread. However, despite the obvious killing of some fungal cells, these neutrophils are not able to completely prevent disease progression and mice suffer strongly from the severe inflammatory processes.
To determine the effect of neutrophil depletion at specific time points in relation to infection, mice were treated with a single 0.1 mg intraperitoneal dose of monoclonal antibody RB6-8C5 (anti-Gr-1; anti-Ly6G/Ly6C). This method of transient neutrophil depletion was chosen because it is well characterized and specific compared with other methods (eg, administration of cyclophosphamide  or irradiation and results in more than 99% depletion in the circulation . Treatment of mice with the anti-neutrophil antibody RB6-8C5 led to a high susceptibility of mice for IA (Figure 1B). However, the luminescence signal was significantly lower than that obtained for cortisone acetate treated mice and the highest values were obtained two days post infection, later than the day 1 peak observed in the cortisone acetate-treated group (Figure 1C).
Monocytes and macrophages are insufficient to prevent conidial germination and hyphal spread in the absence of neutrophils
Taken together, these data indicate that the recruitment of mononuclear cells, in the absence of neutrophils, is insufficient to prevent conidial germination, hyphal outgrowth and tissue infiltration. It is likely that the severe vascular and parenchymal lesions observed in RB6-8C5-treated mice prevented the development of high bioluminescent signals in vivo. This is most likely due to hypoxia resulting from the pulmonary parenchyma destruction, which was even more severe than under cortisone acetate treatment.
Treatment with cyclophosphamide was expected to cause severe neutropenia accompanied by a reduction of monocytes. However, resident alveolar macrophages were not expected to be affected by this treatment. Bioluminescence imaging revealed that cyclophosphamide treatment resulted in a delayed (apparent at day 2 to day 3 post-infection), but steadily increasing bioluminescence signal until mice succumbed to progressive disease (Figure 1C and Figure 2 inlet).
At the late stage of infection, in the absence of inflammatory cells, A. fumigatus disseminates rapidly in cyclophosphamide-treated mice
In this study we successfully imaged murine invasive pulmonary aspergillosis using bioluminescence recordings in a serial manner. We applied different immunosuppression regimens to elucidate their impact on the susceptibility of mice to invasive aspergillosis (IA). By combining bioluminescence imaging and histopathology we gained new insights on the impact of different immune effector cells (mainly macrophages and neutrophils) in host defense against conidial germination and tissue invasion.
Interestingly, under conditions of high inflammation, such as the cortisone acetate or RB6-8C5 treatment, bioluminescence signal intensities nicely reflected the early germination of conidia, but only showed limited correlation with the amount of alive fungal cells at later time points of infection. Quantification of the fungal DNA from late time points of cortisone acetate treated animal implied that the number of living cells stayed constant over time. This result confirmed that neutrophils, although affected in their killing capacity by the corticosteroid, limited the uncontrolled spreading of fungal mycelium through the lung tissues. However, one would have expected that the bioluminescence signal stays at a high level rather than declining. Due to the large necrotic areas (covering approximately 11% of the whole lung parenchyma), we attribute the decline of the bioluminescence signal to the development of hypoxia, as observed in tissues after stroke or myocardial infarction and for growing tumors, which become hypoxic when they outgrow the vascular supply . The limitation of bioluminescence imaging in hypoxic tissues has already been described by investigating the decrease in bioluminescence of luciferase-transfected gliosarcoma tumor cells under defined hypoxic in vitro conditions . Additionally, bioluminescent implanted tumor cells can become necrotic at a certain age with subsequent decline of bioluminescence although the tumor itself does not reduce its size . This latter scenario is likely to be comparable to our results obtained during bioluminescence imaging of invasive aspergillosis under cortisone acetate and RB6-8C5 antibody treatment. In addition, the occurrence of hypoxia has been assumed from the attenuated virulence of A. fumigatus mutants with a defective adaptation to hypoxic conditions  and seems confirmed independently by our bioluminescence measurements. Although the correlation of the bioluminescent signal at later time points with the fungal burden is limited the decline in bioluminescence under in vivo conditions in late stages of infection acts as an indicator of tissue destruction and hypoxia and indicates the imminent death of the animals.
Despite the low correlation of fungal biomass and bioluminescence at late time points after infection in the cortisone acetate and RB6-8C5 treatments, a good correlation between the increase in the fungal biomass and the bioluminescence was observed under the cyclophosphamide regimen. Under this treatment, although the growing hyphae were responsible for diffuse parenchyma lesions, the accessibility of oxygen remains possible in the absence of inflammation. At late time points, an ongoing increase of the luminescence signal reflects the increase of biomass. Therefore, cyclophosphamide immunosuppression seems best suited to follow the effect of antifungal drug treatment on clearance of fungal infections.
This study additionally allowed gaining new insight concerning the impact of different immune effector cells in the defense against invasive aspergillosis. Alveolar macrophages (AM) were assumed to play an important role in clearance of conidia from tissues and provide a "first-line of defense" against A. fumigatus infections . AM are thought to trigger the recruitment of immune effector cells to the site of infection after recognition and phagocytosis of conidia  through the release of inflammatory and chemotactic mediators.
Due to the importance of AM in conidial host defense, we expected that their reduction by the clodrolip treatment would increase the susceptibility of mice to IA. This assumption was not confirmed experimentally. Intranasally clodrolip-treated mice showed a 80% reduction in the number and viability of AM [28, 29], but a 2.6 fold increase in the number of BAL fluid neutrophils, one day post-infection. A significant increase in the neutrophil number in BAL fluid of macrophage-depleted (clodrolip-treated) mice 24 hours after instillation of Pseudomonas aeruginosa has already been reported. However, in this work macrophage-deficient mice showed impaired bacterial clearance . In contrast, in our model, neutrophil migration into the airways of macrophage-depleted infected mice is likely to have prevented conidial germination per se.
Supporting this idea, we found that the thoracic region or BAL fluid of AM-depleted animals only showed a slight increase in bioluminescence above control levels (Figure 3). This finding correlated with survival data and histopathological findings, demonstrating an absence of conidial germination in AM-depleted mice. These results do not fully exclude the possibility that (i) there were still sufficient residual viable alveolar macrophages to trigger an immune response due to only 80% of depletion and (ii) the possibility of recruitment of peripheral monocytes or (iii) that the increase in recruited neutrophils was able to control the infection in the absence of normal alveolar macrophage counts. The first and second scenarios, however, appear rather unlikely, because hardly any macrophages or monocytes were observed in histopathologic analyses at day one after infection. The third scenario appears quite likely, because histopathological analysis revealed a strong infiltration of neutrophils encasing ungerminated conidia. In contrast, functionally attenuated neutrophils and macrophages in corticosteroid-treated mice allowed development of invasive disease despite robust cellular recruitment in the lung parenchyma.
The treatment of mice with cortisone acetate or the combination of clodrolip and cortisone acetate led to 100% mortality and invasive fungal growth within the lung tissue. Although systemic administration of corticosteroids increases the number of circulating neutrophils by three- to fivefold , their ability to damage A. fumigatus hyphae is strongly reduced . One day post-infection, the lung tissue showed an extensive neutrophilic infiltration that surrounded germinating conidia. These neutrophils were able to delay uncontrolled tissue invasion by killing some proportion of fungal hyphae. As a consequence of the neutrophil infiltration severe tissue damage accompanied by parenchymal destruction (necrosis) was observed, leading to a decreased bioluminescence as described above. It is also noteworthy that under cortisone acetate treatment the efficiency of alveolar macrophages in inhibiting conidial germination after phagocytosis was strongly defective. None of the other treatment groups yielded hyphal germlings as early as one day post-infection. It could be assumed that this rapid germination is due to growth stimulation via A. fumigatus corticosteroid receptors . However, experiments, in which different concentrations of cortisone acetate were added to A. fumigatus cultures, neither stimulated conidia germination, nor increased the light emission (data not shown). Since cortisone acetate itself constitutes an "inactive" corticosteroid derivative, which is converted into "active" cortisol during metabolism in the liver , it might be possible that a stimulation of germination is only mediated by this metabolite rather than by cortisone acetate.
Another possibility for the rapid germination of conidia is given by a neutrophil mediated tissue destruction releasing large amounts of nutrients from tissue cells, which enhanced the germination speed under this immunosuppresive regimen. The mild inflammation under RB6-8C5 treatment one day post infection and the absence of inflammation under cyclophosphamide treatment may not provide the same nutritional conditions leading to a delayed germination when compared to the cortisone acetate treatment.
Another piece of evidence that supports the dependence on the number and functional integrity of neutrophils in the clearance of A. fumigatus is the observation that RB6-8C5 treatment renders mice highly susceptible to IA. Our results confirm earlier studies [17, 35, 36, 22] and clearly demonstrate that AM and monocytes cannot functionally compensate for loss of neutrophils. RB6-8C5 treated mice succumbed to IA with a similar time course as cortisone acetate-treated mice. However, a notable difference between both models was the absence of neutrophils and the severe tissue infiltration by mononuclear cells (mainly macrophages) seen in RB6-8C5-treated mice at days three to four after infection. This tissue infiltration covered approximately 19% of the total lung surface and was more severe than observed in the cortisone acetate treatment group (approximately 11%).
Treatment with cyclophosphamide was assumed to have the strongest impact on the development of IA. It results in: (i) a reduction in the number of monocytes and neutrophils in the peripheral blood by 64 and 88%, respectively [37–39], (ii) a reduction in the number of AM and neutrophils in an experimental lung infection with Streptococcus pneumoniae, (iii) an impairment of phagocytosis , (iv) an immune dysfunction through reactive oxygen intermediate-induced damage to the immune system cells [42–44] without alteration of the degranulation process  and finally (v) a failure in neutrophil chemotactic function . As expected, under this treatment, we did not observe inflammation within the infected tissues. Therefore, mice treated with cyclophosphamide succumb to uncontrolled infection resulting in tissue destruction and blood vessel infiltration by the fungal mycelium and the fungal biomass produced under this regimen was by far most pronounced at late time points (Figure 2 and 13). In contrast, cortisone acetate and RB6-8C5 treatment likely results in additional tissue injury due to the strong, but ineffective host inflammatory response.
Interestingly, the luminescence additionally enabled us to detect and monitor extrathoracic growth of A. fumigatus in particular in the sinus area even in cortisone acetate treated mice. The resulting suppurative sinusitis may indicate a defect in the innate immune response in the upper respiratory airway rather than dissemination.
Reflecting on the outcome of aspergillosis from the different infection models, we conclude that AM are likely to be important in orchestrating the early immune response to recruit other immune effector cells. However, although able to slow fungal outgrowth, AM are insufficient to clear the infection in the absence of neutrophils. Neutrophil depletion by the RB6-8C5 antibody leads to a predominately monocyte infiltration to the site of infection. Influx of mononuclear cells is insufficient to replace neutrophil function. Corticosteroid treatment leads to the most rapid germination of conidia, which may reflect functional inactivation of alveolar macrophages followed by the ongoing influx of neutrophils, which are attenuated in their conidial and hyphal killing mechanisms. Although after corticosteroid-treatment, neutrophils were not able to inactivate growing hyphae completely, they retarded hyphal tissue invasion at the great cost of massive tissue inflammation and necrosis. Therefore, preservation of neutrophil number and function is indispensable for the control and clearance of A. fumigatus infections. Macrophages may play an important role in orchestrating the immune response, but their action alone is not sufficient to combat A. fumigatus.
Our data suggest that the early neutrophil recruitment is crucial to form an efficient immune response against A. fumigatus. This assumption is supported by two previous studies, which have reported that mice deficient in the chemokine receptor CXCR2 (CXCR2-/- mice) display a defect in neutrophil recruitment and were more susceptible to IA [36, 35]. Therefore, we conducted a preliminary investigation, in which we used a bioluminescent A. fumigatus strain to monitor the pathogenesis of CXCR2-/- mice. This experiment revealed an overall average of 3-fold increase of bioluminescence signal within the thoracic region of knockout compared to wild type mice. At day 6 post infection, a 12 fold-increase in luminescence was observed in knockout animals with a mortality rate of more than 60%, whereas all immune competent wild-type mice survived (data not shown). Although this experiment has to be confirmed by characterizing the histological lesions, it fits well with the assumption that the early recruitment of immunocompetent neutrophils is one of the most important factors to combat the initial onset of invasive aspergillosis.
Taken together, the bioluminescent A. fumigatus strain provides a valuable tool to define the progressive nature of IA under different immunosuppressive regimens, although the quantification of fungal biomass by bioluminescent imaging was difficult to assess especially under inflammatory conditions. However, in order to confirm that the tendency of the progression of infection is correctly assigned by bioluminescence imaging, we confirmed our results by histopathologic analysis and quantification of the fungal DNA by qRT-PCR. The latter method is the most reliable measure for quantification of living fungal cells, but cannot be used in time response analyses since the animals need to be sacrificed to gain the infected organs. Although larger animal groups and all immunosuppression regimens need to be investigated by quantitative real-time PCR, it appears that bioluminescence imaging cannot be used for replacing alternative methods for quantification if an exact value for fungal biomass in a certain animal and time point needs to be determined. This is mainly due to the fact that bioluminescence does not increase or decrease linearly with the burden as determined by quantitative real-time PCR since determination of light emission from living animals is strongly dependent on availability of oxygen. However, and most importantly, bioluminescence imaging was indeed able reflecting the general tendency of the speed of fungal germination, tissue invasion and inflammatory response. Histopathology revealed a rapid germination of conidia under cortisone acetate treatment and, coinciding, a high bioluminescent signal was obtained. At later stages, neutrophils partially inactivated fungal mycelium and caused tissue necrosis under corticosteroid treatment. In agreement, the bioluminescent signal strongly declined. Contrarily, under cyclophosphamide treatment conidia germination is delayed. Therefore, one day after infection only a weak bioluminescence signal was detected. However, at later time points under this regimen, a strong fungal invasion of the lung parenchyma was observed in histopathology and confirmed by quantification of fungal DNA. Coinciding, the bioluminescence strongly increased. Therefore, bioluminescence signals cannot be used for comparison of the fungal burden among different immunosuppression regimens but within one well-defined regimen, the bioluminescence correlates well with the independently determined fungal germination speed, immune response and the fate of fungal cells within the infected tissue.
By using the bioluminsescence imaging system, we found that experiments that perturb the number, recruitment, and function of neutrophils result in predictable patterns of invasive aspergillosis that can be imaged serially in real time with bioluminescence imaging. In vivo monitoring shows light emission from lungs as soon as 24 hours post infection, indicating rapid outgrowth of the fungus. Therefore, early diagnosis of fungal infections is of tremendous importance. In addition, our study provides new insights into the innate immune response emphasizing an essential role for neutrophils as recruited phagocytes in the early innate response to A. fumigatus.
The currently constructed strain seems most suitable for disease monitoring in host system that have undergone myeloablation (e.g. cyclophosphamide treatment). The reproducible imaging results from small groups of animals and is likely to help in substantial cost savings in trials that examine the effects of pharmaceutical compounds, antibodies, and genetic or cellular lesions in small animal models of IA. In further studies, bioluminescence imaging will be used to assess the efficacy of antifungal drugs under in vivo conditions. A successful monitoring of clearance of fungal infections might help improving future treatment strategies for combating invasive fungal infections.
Strain culturing and mouse infection
A. fumigatus strain C3
The bioluminescent A. fumigatus strain C3  was used in all experiments and was subcultured on 2% malt extract agar slants for 8 days at room temperature. Conidia were harvested by scrapping them from the slant culture with 2 ml of phosphate buffered saline supplemented with 0.1% Tween 20 (PBST). The suspension was filtered through a 40 μm cell strainer (BD Falcon, Bedford MA, USA) to separate conidia from contaminating mycelium.
Male BALB/cJ mice (25 g, 8 week-old) were supplied by the Centre d' Elevage R. Janvier (Le Genest Saint-Isle, France). Mice were fed with normal mouse chow and water ad libitum and were reared and housed under standard conditions with air filtration. Mice were cared for in accordance with Institut Pasteur guidelines in compliance with the European animal welfare regulation. Prior to intranasal infection one of the following immunosuppression regimens was applied:
(i) Cortisone acetate treatment
Cortisone acetate was suspended in sterile phosphate buffered saline (PBS) to give a final concentration of 125 mg/ml. The suspension was sonicated at 37°C for at least 30 min to prepare a homogenous suspension. Immunosuppression was performed as described previously , whereby mice were immunosuppressed with two single doses of 25 mg cortisone acetate (Sigma Aldrich, St Louis, MO), which were injected intraperitoneally three days before and immediately prior to infection with conidia (day 0).
(ii) RB6 purification and treatment
The RB6-8C5 anti-neutrophil antibody was purified from ascites (gift from Robert Coffman, DNAX Corp.) by chromatography over a HiTrap protein G column (1 ml bed volume, GE Healthcare, Freiburg, Germany). Aliquots containing 500 μg of purified antibody in PBS were shock-frozen in liquid nitrogen and stored at -80°C until use. For depletion of neutrophils, each mouse received 100 μg of RB6-8C5 antibody (150 μl) injected intraperitoneally one day prior to infection.
(iii) Cyclophosphamide treatment
For bone marrow stem cell depletion, cyclophosphamide was injected intraperitoneally (200 mg/kg) four and one day prior to infection. The cyclophosphamide injection was repeated every other day post-infection.
(iv) Clodrolip treatment
Clodronate liposomes (Clodrolip) were prepared as described previously [47, 48]. Clodronate was a gift of Farchemia, Treviglio, Italy. The liposomes act as carriers for clodronate, which is toxic for phagocytic cells. Two days prior infection, a volume of 83 μl containing 1.5 mg of Clodrolip was directly instilled into the nares of anesthetized mice to deplete alveolar macrophages. Mice instilled with empty liposomes were used as controls.
Additionally, certain mice received both clodrolip and cortisone acetate. This regimen included one dose of cortisone acetate and clodrolip at day -3, clodrolip alone at day -2 and cortisone acetate alone at the day of infection.
Mice were anesthetised by an intramuscular injection of 0.1 ml of a solution containing 10 mg ketamine (Imalgène 1000, Merial, Lyon, France) and 0.8 mg xylazine (Bayer, Leverkusen, Germany) per mouse. 2 × 106 conidia in 25 μl of PBS 0.1% Tween 20 were applied to the nares of the mice. Deep anaesthesia ensured inhalation of the conidial inoculum. Infected mice were daily monitored by bioluminescence imaging using an IVIS 100 system (Xenogen Corporation, Alameda, CA, USA). Weight loss was monitored at 24 h intervals starting from day -4. In all experiments, mice were kept for a maximum of 15 days post infection.
Bronchoalveolar lavage (BAL) fluid was harvested as previously described . Mice were euthanized by injection of Pentobarbital (Sanofi Santé Animale, Libourne, France) and the respiratory tract was exposed by dissection. A small incision was made near the top of the trachea, and a blunt-end 20-gauge needle was inserted and tied in place with surgical thread around the trachea. BAL fluid was obtained by 10 rounds of filling the lungs with 0.7 ml PBS and withdrawing as much of the liquid as possible. The samples were centrifuged to collect BAL fluid cells. BAL fluid cells were washed and resuspended in 1 ml PBS and aliquots were removed for counting with a hemocytometer and for cytospin centrifugation on a microscope slide, followed by DNA staining with Hoechst 33342 for identification of cell types. To determine the numbers of macrophages and neutrophils in the samples, 100 cells from several microscopy fields were identified.
Flow cytometry using macrophage marker antibodies F4/80 (Miltenyi-Biotec, Bergisch Gladbach, Germany) and Gr-1 (Biolegend, San diego CA USA) was used to verify the extent of macrophage depletion within the BAL of clodrolip treated animals. Cell viability was evaluated using the trypan dye exclusion (Sigma-Aldrich).
In vivo and in vitro imaging of bioluminescence
Images were acquired using an IVIS 100 system according to the manufacturer's instructions and as previously described . In brief, 100 μl of PBS containing 3.33 mg D-luciferin was intraperitoneally injected in mice before each measurement. Mice were anesthetized using a constant flow of 2.5% isofluorane mixed with oxygen using an XGI-8 gas anesthesia system (Xenogen Corporation). Images from mice were acquired 10 min after luciferin injection. Acquisition and quantification were performed using Living Image software version 3.1 (Xenogen Corporation). Quantification of photons per second emitted by each organ was performed by defining regions of interest corresponding to the respective organ of interest. The presence of A. fumigatus within the different organs was confirmed by histopathological analysis.
For in vitro measurement of fungal germination within the BAL, D-luciferin in a final concentration of 10 mM was added directly to cells pelleted at the surface of chamber slides. The reaction was pre-incubated for 10 min at room temperature and measurement was performed with the IVIS 100 system.
Determination of fungal DNA from infected lungs by quantitative real-time PCR
A quantitative real-time PCR approach was selected to determine the fungal burden by quantification of the amount of fungal DNA among the total DNA isolated from lung tissues. The lung of a mouse not infected with A. fumigatus served as negative control. Four mice either immunosuppressed with cortisone acetate or with cyclophosphamide were infected intranasally with 2 × 106 conidia of the bioluminescent strain C3. From each group two were sacrificed on day 1 after infection (early time point) and two mice at day 3 (late time point). The control mouse was sacrificed on day three. Bioluminescence at the early time point was measured from alive animals, whereas at the late time point bioluminescence was additionally recorded from explanted lungs by direct injection of D-luciferin. Lungs were cut into small pieces and briefly washed in phosphate buffered saline. Excess liquid was removed on paper tissues and the weight of lungs was determined. The complete lung from each animal was frozen in liquid nitrogen and ground to a fine powder. Approximately 100 mg of each powdered lung was used for DNA extraction via the MasterPure yeast DNA extraction kit (Epicentre Biotechnologies, Biozym Scientific GmbH, Hessisch Oldendorf, Germany) as described in the manufacturer's protocol. As a slight modification and for obtaining DNA of higher purity grade, an ethanol precipitation step of the DNA was included. The amount of DNA extracted from the lung tissues was quantified by a NanoDrop spectrophotometer. All samples were diluted to 100 ng/μl and quantified again to confirm the DNA concentration of each sample. As a standard for quantification of the amount of fungal DNA among the total DNA extracted from lung tissues, A. fumigatus genomic DNA was isolated by the same procedure from a culture grown for 20 h on minimal medium containing glucose (50 mM) and peptone (0.5% w/v) as nutrient sources. The TaqMan quantitative real-time PCR approach used based on the standard operation procedure (SOP) described elsewhere http://www.sacmm.org/pdf/Determination%20of%20Tissue%20Fungal%20Burden%20utilizing%20Quantitative%20Real%20Time%20PCR.pdf. The TaqMan® Universal PCR Master Mix (Applied Biosystems, Darmstadt, Germany) was used in all approaches. In brief, the genomic DNA region coding for the 18S rRNA from A. fumigatus was used as the target for amplification and quantification of fungal DNA. A specific probe containing a 6-FAM-phosphoramidit labeling at the 5'-end and a TAMRA labeling at the 3'-end was used for detection of the amplification products. Amplification was performed on a StepOnePlus Real-Time PCR system (Applied Biosystems) and data were evaluated by using the StepOne software version 2.0 (Applied Biosystems). The standard curve on genomic DNA from A. fumigatus was generated from three technical replicates, whereby each replicate contained 6 dilutions in the range between 100 and 3.125 ng per reaction (stability index of standard curve = 0.99). The amplification program consisted of an initial denaturation at 95°C for 10 min followed by 40 cycles with denaturation for 15 s at 95°C, annealing for 30 s at 54°C, and amplification for 30 s at 72°C. All DNA samples from lung tissues were measured from 3 dilutions (from 500 to 125 ng total DNA per reaction) in two technical replicates. All six data points from each sample were used for calculation of the amount of fungal DNA per μg of total DNA.
For the histopathological analysis, a group of five mice was studied at each time point (early and late time point), for each immunosuppressive condition. After necropsy, organs of interest (lung, nasal sinus, and brain) were immediately fixed in 4% neutral-buffered formalin and embedded in paraffin. Mouse skull and sinus histological analyses required decalcification in a solution of 4% buffered formalin and 10% trichloroacetic acid for approximately 2 months. Five μm sections were cut and stained with hematoxylin and eosin (HE) and Grocott's methenamine silver (GMS, for detection of fungi) . The lesion profiles were very similar between mice of the same group.
The presence of conidia and hyphae were quantified as evaluated in general in histology within tissue thin sections. This semiquantitative fungal burden is presented as follow: - none, +/- minimal, + mild, ++ moderate, +++ marked, ++++ severe.
The total surface of inflammatory cell infiltrates in tissue sections was measured by morphometric analysis in 22 to 40 microscopic fields, covering an entire lung section for each animal, at 4× magnification. Three mice were analyzed for each immunosuppressive condition. ImageJ 1.38× software (National Institute of Health, USA) was used for this analysis. Reliability was assessed by 20 repeated measurements over several days (coefficient of variation: 1.6%).
All experiments were performed at least in triplicate with groups of 5 mice for each treatment. Comparisons between multiple groups were performed using one-way ANOVA. Significance between groups was determined with the Fisher's Least Significant Difference post hoc test. A p value of < 0.05 was considered statistically significant. Data are reported in the figures as means ± standard deviation.
We would like to express our thanks to Dr M. Huerre, from the URE Histotechnologie et Pathologie at the Institut Pasteur of Paris, for his advices and helpful suggestions and to M-A. Nicola from the Plate-forme d'Imagerie Dynamique at the Institut Pasteur for her assistance with the IVIS system. In addition, we express our gratitude to T. Angelique for his consistent aid in the animal facilities.
This work was supported by grants of the Hans Knoell-Institute (MB), a Roux Fellowship from the Institut Pasteur (GJ) and funding from the Institut Pasteur through a Programme Tansversal de Recherche (OI-G).
- Ellis M: Febrile neutropenia. Ann N Y Acad Sci. 2008, 1138: 329-350. 10.1196/annals.1414.035.View ArticlePubMedGoogle Scholar
- Lin SJ, Schranz J, Teutsch SM: Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis. 2001, 32 (3): 358-366. 10.1086/318483.View ArticlePubMedGoogle Scholar
- Segal BH: Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. Oncologist. 2007, 12 (Suppl 2): 7-13.PubMedGoogle Scholar
- Singh N: Invasive aspergillosis in organ transplant recipients: new issues in epidemiologic characteristics, diagnosis, and management. Med Mycol. 2005, 43 (Suppl 1): S267-270. 10.1080/13693780500051984.View ArticlePubMedGoogle Scholar
- Marr KA, Carter RA, Boeckh M, Martin P, Corey L: Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002, 100 (13): 4358-4366. 10.1182/blood-2002-05-1496.View ArticlePubMedGoogle Scholar
- Garcia-Vidal C, Upton A, Kirby KA, Marr KA: Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis. 2008, 47 (8): 1041-1050. 10.1086/591969.PubMed CentralView ArticlePubMedGoogle Scholar
- Lionakis MS, Kontoyiannis DP: Glucocorticoids and invasive fungal infections. Lancet. 2003, 362 (9398): 1828-1838. 10.1016/S0140-6736(03)14904-5.View ArticlePubMedGoogle Scholar
- Philippe B, Ibrahim-Granet O, Prevost MC, Gougerot-Pocidalo MA, Sanchez Perez M, Meeren Van der A, Latge JP: Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun. 2003, 71 (6): 3034-3042. 10.1128/IAI.71.6.3034-3042.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Ibrahim-Granet O, Philippe B, Boleti H, Boisvieux-Ulrich E, Grenet D, Stern M, Latge JP: Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun. 2003, 71 (2): 891-903. 10.1128/IAI.71.2.891-903.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Romani L, Montagnoli C, Bozza S, Perruccio K, Spreca A, Allavena P, Verbeek S, Calderone RA, Bistoni F, Puccetti P: The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol. 2004, 16 (1): 149-161. 10.1093/intimm/dxh012.View ArticlePubMedGoogle Scholar
- Bellocchio S, Moretti S, Perruccio K, Fallarino F, Bozza S, Montagnoli C, Mosci P, Lipford GB, Pitzurra L, Romani L: TLRs govern neutrophil activity in aspergillosis. J Immunol. 2004, 173 (12): 7406-7415.View ArticlePubMedGoogle Scholar
- Hohl TM, Van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, Pamer EG: Aspergillus fumigatus Triggers Inflammatory Responses by Stage-Specific beta-Glucan Display. PLoS Pathog. 2005, 1 (3): e30-10.1371/journal.ppat.0010030.PubMed CentralView ArticlePubMedGoogle Scholar
- Steele C, Rapaka RR, Metz A, Pop SM, Williams DL, Gordon S, Kolls JK, Brown GD: The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog. 2005, 1 (4): e42-10.1371/journal.ppat.0010042.PubMed CentralView ArticlePubMedGoogle Scholar
- Gersuk GM, Underhill DM, Zhu L, Marr KA: Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol. 2006, 176 (6): 3717-3724.View ArticlePubMedGoogle Scholar
- Chignard M, Balloy V, Sallenave JM, Si-Tahar M: Role of Toll-like receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol. 2007, 124 (3): 238-243. 10.1016/j.clim.2007.05.004.View ArticlePubMedGoogle Scholar
- Brock M, Jouvion G, Droin-Bergere S, Dussurget O, Nicola MA, Ibrahim-Granet O: Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol. 2008, 74 (22): 7023-7035. 10.1128/AEM.01288-08.PubMed CentralView ArticlePubMedGoogle Scholar
- Stephens-Romero SD, Mednick AJ, Feldmesser M: The pathogenesis of fatal outcome in murine pulmonary aspergillosis depends on the neutrophil depletion strategy. Infect Immun. 2005, 73 (1): 114-125. 10.1128/IAI.73.1.114-125.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- van Rooijen N: Liposomes for targeting of antigens and drugs: immunoadjuvant activity and liposome-mediated depletion of macrophages. J Drug Target. 2008, 16 (7): 529-534. 10.1080/10611860802228426.View ArticlePubMedGoogle Scholar
- Robertson JB, Stowers CC, Boczko E, Johnson CH: Real-time luminescence monitoring of cell-cycle and respiratory oscillations in yeast. Proc Natl Acad Sci USA. 2008, 105 (46): 17988-17993. 10.1073/pnas.0809482105.PubMed CentralView ArticlePubMedGoogle Scholar
- Ibrahim-Granet O, Dubourdeau M, Latge JP, Ave P, Huerre M, Brakhage AA, Brock M: Methylcitrate synthase from Aspergillus fumigatus is essential for manifestation of invasive aspergillosis. Cell Microbiol. 2008, 10 (1): 134-148.PubMedGoogle Scholar
- Moreno MA, Ibrahim-Granet O, Vicentefranqueira R, Amich J, Ave P, Leal F, Latge JP, Calera JA: The regulation of zinc homeostasis by the ZafA transcriptional activator is essential for Aspergillus fumigatus virulence. Mol Microbiol. 2007, 64 (5): 1182-1197. 10.1111/j.1365-2958.2007.05726.x.View ArticlePubMedGoogle Scholar
- Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM: Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis. 2009, 200 (4): 647-656. 10.1086/600380.PubMed CentralView ArticlePubMedGoogle Scholar
- Krohn KA, Link JM, Mason RP: Molecular imaging of hypoxia. J Nucl Med. 2008, 49 (Suppl 2): 129S-148S. 10.2967/jnumed.107.045914.View ArticlePubMedGoogle Scholar
- Moriyama EH, Niedre MJ, Jarvi MT, Mocanu JD, Moriyama Y, Subarsky P, Li B, Lilge LD, Wilson BC: The influence of hypoxia on bioluminescence in luciferase-transfected gliosarcoma tumor cells in vitro. Photochem Photobiol Sci. 2008, 7 (6): 675-680. 10.1039/b719231b.View ArticlePubMedGoogle Scholar
- Lim E, Modi KD, Kim J: In vivo bioluminescent imaging of mammary tumors using IVIS spectrum. J Vis Exp. 2009, 26Google Scholar
- Willger SD, Grahl N, Cramer RA: Aspergillus fumigatus metabolism: clues to mechanisms of in vivo fungal growth and virulence. Med Mycol. 2009, 47 (Suppl 1): S72-79. 10.1080/13693780802455313.PubMed CentralView ArticlePubMedGoogle Scholar
- Cornish EJ, Hurtgen BJ, McInnerney K, Burritt NL, Taylor RM, Jarvis JN, Wang SY, Burritt JB: Reduced nicotinamide adenine dinucleotide phosphate oxidase-independent resistance to Aspergillus fumigatus in alveolar macrophages. J Immunol. 2008, 180 (10): 6854-6867.View ArticlePubMedGoogle Scholar
- Huitinga I, Damoiseaux JG, van Rooijen N, Dopp EA, Dijkstra CD: Liposome mediated affection of monocytes. Immunobiology. 1992, 185 (1): 11-19.View ArticlePubMedGoogle Scholar
- Schmidt-Weber CB, Rittig M, Buchner E, Hauser I, Schmidt I, Palombo-Kinne E, Emmrich F, Kinne RW: Apoptotic cell death in activated monocytes following incorporation of clodronate-liposomes. J Leukoc Biol. 1996, 60 (2): 230-244.PubMedGoogle Scholar
- Manicone AM, Birkland TP, Lin M, Betsuyaku T, van Rooijen N, Lohi J, Keski-Oja J, Wang Y, Skerrett SJ, Parks WC: Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol. 2009, 182 (6): 3866-3876. 10.4049/jimmunol.0713949.PubMed CentralView ArticlePubMedGoogle Scholar
- Schleimer RP: Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc. 2004, 1 (3): 222-230. 10.1513/pats.200402-018MS.View ArticlePubMedGoogle Scholar
- Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ: Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun. 1993, 61 (11): 4870-4877.PubMed CentralPubMedGoogle Scholar
- Ng TT, Robson GD, Denning DW: Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology. 1994, 140 (Pt 9): 2475-2479. 10.1099/13500872-140-9-2475.View ArticlePubMedGoogle Scholar
- Swords FM, Carroll PV, Kisalu J, Wood PJ, Taylor NF, Monson JP: The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement. Clin Endocrinol (Oxf). 2003, 59 (5): 613-620. 10.1046/j.1365-2265.2003.01894.x.View ArticleGoogle Scholar
- Mehrad B, Moore TA, Standiford TJ: Macrophage inflammatory protein-1 alpha is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts. J Immunol. 2000, 165 (2): 962-968.View ArticlePubMedGoogle Scholar
- Bonnett CR, Cornish EJ, Harmsen AG, Burritt JB: Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia. Infect Immun. 2006, 74 (12): 6528-6539. 10.1128/IAI.00909-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Kaneko M, Kawakita T, Kumazawa Y, Takimoto H, Nomoto K, Yoshikawa T: Accelerated recovery from cyclophosphamide-induced leukopenia in mice administered a Japanese ethical herbal drug, Hochu-ekki-to. Immunopharmacology. 1999, 44 (3): 223-231. 10.1016/S0162-3109(99)00050-8.View ArticlePubMedGoogle Scholar
- Hirsh M, Carmel J, Kaplan V, Livne E, Krausz MM: Activity of lung neutrophils and matrix metalloproteinases in cyclophosphamide-treated mice with experimental sepsis. Int J Exp Pathol. 2004, 85 (3): 147-157. 10.1111/j.0959-9673.2004.00385.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Montillo M, Tedeschi A, O'Brien S, Di Raimondo F, Lerner S, Ferrajoli A, Morra E, Keating MJ: Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia. Cancer. 2003, 97 (1): 114-120. 10.1002/cncr.11000.View ArticlePubMedGoogle Scholar
- Calame W, Douwes-Idema AE, Barselaar van den MT, Mattie H: Contribution of alveolar phagocytes to antibiotic efficacy in an experimental lung infection with Streptococcus pneumoniae. J Infect. 2001, 42 (4): 235-242. 10.1053/jinf.2001.0837.View ArticlePubMedGoogle Scholar
- Gadeberg OV, Rhodes JM, Larsen SO: The effect of various immunosuppressive agents on mouse peritoneal macrophages and on the in vitro phagocytosis of Escherichia coli O4:K3:H5 and degradation of 125I-labelled HSA-antibody complexes by these cells. Immunology. 1975, 28 (1): 59-70.PubMed CentralPubMedGoogle Scholar
- Muruganandan S, Lal J, Gupta PK: Immunotherapeutic effects of mangiferin mediated by the inhibition of oxidative stress to activated lymphocytes, neutrophils and macrophages. Toxicology. 2005, 215 (1-2): 57-68. 10.1016/j.tox.2005.06.008.View ArticlePubMedGoogle Scholar
- Kaufmann SH, Hahn H, Diamantstein T: Relative susceptibilities of T cell subsets involved in delayed-type hypersensitivity to sheep red blood cells to the in vitro action of 4-hydroperoxycyclophosphamide. J Immunol. 1980, 125 (3): 1104-1108.PubMedGoogle Scholar
- Murata M, Ohnishi S, Seike K, Fukuhara K, Miyata N, Kawanishi S: Oxidative DNA damage induced by carcinogenic dinitropyrenes in the presence of P450 reductase. Chem Res Toxicol. 2004, 17 (12): 1750-1756. 10.1021/tx0497550.View ArticlePubMedGoogle Scholar
- Mendonca MA, Cunha FQ, Murta EF, Tavares-Murta BM: Failure of neutrophil chemotactic function in breast cancer patients treated with chemotherapy. Cancer Chemother Pharmacol. 2006, 57 (5): 663-670. 10.1007/s00280-005-0086-4.View ArticlePubMedGoogle Scholar
- Schobel F, Ibrahim-Granet O, Ave P, Latge JP, Brakhage AA, Brock M: Aspergillus fumigatus does not require fatty acid metabolism via isocitrate lyase for development of invasive aspergillosis. Infect Immun. 2007, 75 (3): 1237-1244. 10.1128/IAI.01416-06.PubMed CentralView ArticlePubMedGoogle Scholar
- Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, Schwendener RA: Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol. 1997, 27 (10): 2626-2633. 10.1002/eji.1830271023.View ArticlePubMedGoogle Scholar
- Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'Sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM: CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med. 2005, 11 (11): 1180-1187. 10.1038/nm1303.View ArticlePubMedGoogle Scholar
- Sinha BK, Monga DP, Prasad S: A combination of Gomori-Grocott methenamine silver nitrate and hematoxylene and eosin staining technique for the demonstration of Candida albicans in tissue. Quad Sclavo Diagn. 1988, 24 (1-4): 129-132.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.